News

Now Offering Both 1.5 and 3 Tesla Indications for MR-Conditional ICMs, Pacemakers, ICDs and CRT-Ds Medtronic plc announced that it has received CE (Conformité Européenne) Mark for the first and only cardiac resynchronization therapy...

Boston Scientific Corporation announced the Centers for Medicare and Medicaid Services (CMS) will cover percutaneous left atrial appendage closure (LAAC) therapy under specific criteria, as outlined in the agency's final National Coverage...

The Spectranetics Corporation announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) clearance of the Bridge Occlusion Balloon for temporary vessel occlusion in cardiac lead extraction procedures. The Bridge Occlusion...

Bristol-Myers Squibb Company and Pfizer Inc. announced that the companies have entered into a collaboration agreement with Portola Pharmaceuticals Inc. to develop and commercialize the investigational agent andexanet alfa in Japan. Andexanet...

Abbott announced that it has acquired Kalila Medical, Inc., a private medical device company developing next-generation access technologies used in cardiac electrophysiology procedures for the treatment of heart rhythm disorders,...

AliveCor, Inc., the leader in FDA-cleared ECG technology for mobile devices, announced a strategic partnership with LifeWatch AG, a leading developer of medical solutions and remote diagnostic monitoring services to the digital health market....

Cardiome Pharma Corp. announced that one of its subsidiaries has entered into an agreement with Chong Kun Dang Pharmaceuticals ("CKD") to commercialize BRINAVESS® (vernakalant HCl) in South Korea. CKD will be responsible for obtaining the...

BIOTRONIK’s Iperia Series of ICDs and Leads Allow Broadest Range of Patient Access to MRI Diagnostic Options BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced that it has received Food and Drug...

The collaborative study is the first international prospective randomized multicenter study of its kind December 17, 2015 06:00 AM Eastern Standard Time WEST CHESTER, Ohio--(BUSINESS WIRE)--AtriCure, Inc., a leading innovator in...

VANCOUVER, Dec. 22, 2015 /PRNewswire/ - Cardiome Pharma Corp. announced the filing of a New Drug Submission (NDS) with Health Canada's Therapeutic Products Directorate (TPD) seeking Canadian approval of intravenous vernakalant for the...